Crossref

1. CHARACTERISTICS OF LEVELS OF SERUM MARKERS OF APOPTOSIS FAS-SYSTEMS IN HIV-MONO-INFECTED PERSONS, PATIENTS WITH HIV/HCV-CO-INFECTION AND CHRONIC VIRAL HEPATITIS C

- E. A. Bazykina

- V. B. Turkutyukov

- O. E. Trotsenko

- V. O. Kotova

- L. A. Balakhontseva

2. Synergistic interaction of the cannabinoid and death receptor systems – a potential target for future cancer therapies?

- Attila Keresztes

- John M. Streicher

3. Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation

- Zhen-Tang Jing

- Wei Liu

- Shu-Xiang Wu

- Yun He

- Yan-Ting Lin

- Wan-Nan Chen

- Xin-Jian Lin

- Xu Lin

4. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis

- Ben-sheng Dong

- Fu-qun Liu

- Wen-na Yang

- Xiao-dong Li

- Miao-juan Shi

- Mao-rong Li

- Xiu-li Yan

- Hui Zhang

5. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients

- Mohamed El-Mesery

- Mohammed El-Mowafy

- Abdelaziz Elgaml

- Laila F. Youssef

- Sally Y. Abed

6. Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection

- Claudio Mastroianni

- Miriam Lichtner

- Claudia Mascia

- Paola Zuccalà

- Vincenzo Vullo

7. Expression of cluster of differentiation-95 and relevant signaling molecules in liver cancer

- XUMING WANG

- KANGLAI WEI

- QIONGGUANG ZHANG

- SIEN ZENG

- JING LIN

- LI QIAO

- LIJIANG LIU

8. Role of Apoptosis in HIV Pathogenesis

- Cyril Jabea Ekabe

- Njinju Asaba Clinton

- Eugene Kusi Agyei

- Jules Kehbila

- Majid Jabir

9. Exploring multiple quantitative trait loci models of hepatic fibrosis in a mouse intercross

- Rabea A. Hall

- Sonja Hillebrandt

- Frank Lammert

10.

11.

12. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection

- S. Tsiomita

- U. Georgopoulou

- P.P. Doumba

- J. Koskinas

- K. Adamidis

- C. Papaloukas

- G. Thyphronitis

13. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score

- El-Shatat A. Toson

- Gamal E. Shiha

- Hatem A. El-Mezayen

- Aml M. El-Sharkawy

14. IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans

- Fawaz Alzaid

- Floriane Lagadec

- Miguel Albuquerque

- Raphaëlle Ballaire

- Lucie Orliaguet

- Isabelle Hainault

- Corinne Blugeon

- Sophie Lemoine

- Agnès Lehuen

- David G. Saliba

- Irina A. Udalova

- Valérie Paradis

- Fabienne Foufelle

- Nicolas Venteclef

15. Intestinal IL-17R Signaling Constrains IL-18-Driven Liver Inflammation by the Regulation of Microbiome-Derived Products

- Patricia Castillo-dela Cruz

- Alanna G. Wanek

- Pawan Kumar

- Xiaojing An

- Waleed Elsegeiny

- William Horne

- Adam Fitch

- Ansen H.P. Burr

- Kathyayini P. Gopalakrishna

- Kong Chen

- Barbara A. Methé

- Scott W. Canna

- Timothy W. Hand

- Jay K. Kolls

16. Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells

- Qiuyue Zhang

- Jinchen Liu

- Haifeng Lin

- Bo Lin

- Mingyue Zhu

- Mengsen Li

17. Balance of apoptotic and anti-apoptotic marker and perforin granule release in squamous intraepithelial lesions. HIV infection leads to a decrease in perforin degranulation

- Ana Teresa G. Fernandes

- Natalia Pereira da Rocha

- Elyzabeth Avvad

- Beatriz J. Grinsztejn

- Fabio Russomano

- Aparecida Tristão

- Marcel de Souza Borges Quintana

- Mauricio A. Perez

- Fátima Conceição-Silva

- Maria da Gloria Bonecini-Almeida

18. Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease

- Francisco Javier Cubero

- Marius Maximilian Woitok

- Miguel E. Zoubek

- Alain de Bruin

- Maximilian Hatting

- Christian Trautwein

19. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy

- Li-Li Han